0001437749-22-026086.txt : 20221107
0001437749-22-026086.hdr.sgml : 20221107
20221104185909
ACCESSION NUMBER: 0001437749-22-026086
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20221107
DATE AS OF CHANGE: 20221104
EFFECTIVENESS DATE: 20221107
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Statera Biopharma, Inc.
CENTRAL INDEX KEY: 0001318641
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200077155
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-463987
FILM NUMBER: 221363428
BUSINESS ADDRESS:
STREET 1: 2537 RESEARCH BOULEVARD, SUITE 201
CITY: FORT COLLINS
STATE: CO
ZIP: 80526
BUSINESS PHONE: (888) 613-8802
MAIL ADDRESS:
STREET 1: 2537 RESEARCH BOULEVARD, SUITE 201
CITY: FORT COLLINS
STATE: CO
ZIP: 80526
FORMER COMPANY:
FORMER CONFORMED NAME: Cytocom, Inc.
DATE OF NAME CHANGE: 20210728
FORMER COMPANY:
FORMER CONFORMED NAME: CLEVELAND BIOLABS INC
DATE OF NAME CHANGE: 20050222
D
1
primary_doc.xml
X0708
D
LIVE
0001318641
Statera Biopharma, Inc.
4333 Corbett Drive
Suite 1082
Fort Collins
CO
COLORADO
80525
(888) 613-8802
DELAWARE
None
Cytocom, Inc.
CLEVELAND BIOLABS INC
Corporation
true
Michael
Kevin
Handley
4333 Corbett Drive
Suite 1082
Fort Collins
CO
COLORADO
80525
Executive Officer
Director
Promoter
Blake
Hawley
4333 Corbett Drive
Suite 1082
Fort Collins
CO
COLORADO
80525
Director
John
Kallassy
4333 Corbett Drive
Suite 1082
Fort Collins
CO
COLORADO
80525
Director
Christopher
Zosh
4333 Corbett Drive
Suite 1082
Fort Collins
CO
COLORADO
80525
Executive Officer
Robert
Buckheit
4333 Corbett Drive
Suite 1082
Fort Collins
CO
COLORADO
80525
Executive Officer
Payroll
Satish
Chandren
4333 Corbett Drive
Suite 1082
Fort Collins
CO
COLORADO
80525
Director
Uday
Saxena
4333 Corbett Drive
Suite 1082
Fort Collins
CO
COLORADO
80525
Director
Biotechnology
$1,000,001 - $5,000,000
- 06b
false
2022-11-01
false
true
true
false
50000
764500
577000
187500
false
12
0
0
577000
true
General Corporate Expenses
false
Statera Biopharma, Inc.
/s/ Michael K. Handley
Michael K. Handley
CEO and President
2022-11-04